 rel preval risk factor htlv-i htlv-ii infect US blood donor clinic signific human t-cell lymphotrop viru type II htlv-ii infect htlv-i unknown major associ htlv-ii seroposit intraven drug abus screen blood donor htlv-i north america retroviru htlv-ii seroepidemiolog risk factor htlv II blood volunt donor separ US urban centr antibodi htlv-i/ii confirm htlv-i/ii seroposit donor dna amplif type type II interview possibl risk factor htlv seropreval time vs dna amplif htlv-i/ii seroposit donor htlv-ii infect htlv-i sampl uninform interview donor wherea htlv-i donor origin endem region major risk factor htlv-ii infect intraven drug use high rate htlv-ii infect US blood donor import public health donor counsel issu htlv-i infect adult t-cell leukaemia neurolog disord pathogen htlv-ii unclear